IN2014MU00072A - - Google Patents

Info

Publication number
IN2014MU00072A
IN2014MU00072A IN72MU2014A IN2014MU00072A IN 2014MU00072 A IN2014MU00072 A IN 2014MU00072A IN 72MU2014 A IN72MU2014 A IN 72MU2014A IN 2014MU00072 A IN2014MU00072 A IN 2014MU00072A
Authority
IN
India
Prior art keywords
rivaroxaban
preparation
pharmaceutically acceptable
acceptable salt
present
Prior art date
Application number
Other languages
English (en)
Inventor
Jagdish Dattopant Shukla
Ramprasad Yadav
Arvind Yekanathsa Merwade
Keshav Deo
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/067072 priority Critical patent/WO2015104605A1/en
Priority to IN72MU2014 priority patent/IN2014MU00072A/en
Publication of IN2014MU00072A publication Critical patent/IN2014MU00072A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
IN72MU2014 2014-01-08 2014-12-18 IN2014MU00072A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/067072 WO2015104605A1 (en) 2014-01-08 2014-12-18 A process for preparing rivaroxaban or a pharmaceutically acceptable salt thereof
IN72MU2014 IN2014MU00072A (es) 2014-01-08 2014-12-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN72MU2014 IN2014MU00072A (es) 2014-01-08 2014-12-18

Publications (1)

Publication Number Publication Date
IN2014MU00072A true IN2014MU00072A (es) 2015-08-21

Family

ID=53523577

Family Applications (1)

Application Number Title Priority Date Filing Date
IN72MU2014 IN2014MU00072A (es) 2014-01-08 2014-12-18

Country Status (2)

Country Link
IN (1) IN2014MU00072A (es)
WO (1) WO2015104605A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210163423A1 (en) * 2015-02-17 2021-06-03 Neupharma, Inc. Certain chemical entities, compositions, and methods

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3740716B2 (ja) * 1994-08-04 2006-02-01 和光純薬工業株式会社 アシルチオコリン誘導体およびその用途
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE102004002044A1 (de) 2004-01-15 2005-08-04 Bayer Healthcare Ag Herstellverfahren
JP2006056812A (ja) * 2004-08-19 2006-03-02 Ube Ind Ltd ６，６−ジフルオロ−５−ヘキセン−１−チオール誘導体及び農園芸用の有害生物防除剤
DE102006048042A1 (de) * 2006-10-11 2008-04-17 Bayer Healthcare Ag Acylaminoimidazole und Acylaminothiazole
US7816355B1 (en) 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof
WO2011012321A1 (en) 2009-07-31 2011-02-03 Krka, D.D., Novo Mesto Processes for crystallization of rivaroxaban
CN102822167A (zh) 2010-01-04 2012-12-12 埃南蒂亚有限公司 用于制备利伐沙班的方法及其中间体
EP2354128A1 (en) 2010-02-10 2011-08-10 Sandoz Ag Method for the preparation of rivaroxaban
MD4557C1 (ro) 2011-05-06 2018-10-31 Egis Gyogysszegyar Nyilvanosan Mukodo Reszvenytarsasag Procedeu de obţinere a rivaroxabanului şi un compus intermediar utilizat în acest procedeu
WO2012156983A1 (en) 2011-05-16 2012-11-22 Symed Labs Limited Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
EP2753619A2 (en) 2011-09-08 2014-07-16 Cadila Healthcare Limited Processes and intermediates for preparing rivaroxaban
WO2013053739A1 (en) 2011-10-10 2013-04-18 Laboratorios Lesvi, S. L. Process for preparing factor xa inhibitors
CZ2012114A3 (cs) 2012-02-17 2013-02-20 Zentiva, K.S. Zpusob prípravy rivaroxabanu zalozený na úspore 1,1´ -karbonyldiimidazolu
US9562040B2 (en) 2012-04-06 2017-02-07 Indiana University Research And Technology Corporation Processes for preparing Rivaroxaban
AU2013250801A1 (en) 2012-04-16 2014-11-06 Sun Pharmaceutical Industries Limited Process for the preparation of rivaroxaban and intermediates thereof
ES2871811T3 (es) 2012-05-02 2021-11-02 Symed Labs Ltd Proceso mejorado para preparar rivaroxabán utilizando intermedios novedosos
CN104098556B (zh) * 2013-04-09 2019-01-08 浙江九洲药物科技有限公司 一种利伐沙班的合成工艺

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210163423A1 (en) * 2015-02-17 2021-06-03 Neupharma, Inc. Certain chemical entities, compositions, and methods

Also Published As

Publication number Publication date
WO2015104605A1 (en) 2015-07-16

Similar Documents

Publication Publication Date Title
MX2017006266A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos.
MX2020001278A (es) Sintesis de compuestos de carbamoilpiridona policiclica.
GR20140100479A (el) Συνθεση λιραγλουτιδης
IN2014CH00247A (es)
MX2016016297A (es) Procedimientos para la preparacion de compuestos antivirales.
PH12017500833A1 (en) Synthesis of copanlisib and its dihydrochloride salt
JO3487B1 (ar) تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به
MX2020003020A (es) Compuestos de aminocarbonilcarbamato.
PH12016501613A1 (en) Pyrazines modulators of gpr6
PH12017501404A1 (en) Diaza-benzofluoranthrene compounds
IN2014MU01192A (es)
IN2014MU00195A (es)
MX2016015465A (es) Composicion farmaceutica oral de isotretinoina.
MX2019001228A (es) Metodo de produccion del compuesto de pirazol-amida.
MX2016015298A (es) Inhibidores de nampt y metodos.
IN2014MU00072A (es)
IN2014MU00194A (es)
IN2014MU01196A (es)
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2017004770A (es) Formas solidas del clorhidrato de nilotinib.
IN2013MU03670A (es)
IN2014MU00070A (es)
IN2014MU00566A (es)
IN2014MU00858A (es)